1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jelic S and Sotiropoulos G: Hepatocellular
carcinoma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 21:v59–v64. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Croce C, Calin G and Volinia S:
MicroRNA-based methods and compositions for the diagnosis and
treatment of solid cancers Patent CN101389770A. 2012
|
6
|
Li A, Yu J, Kim H, et al: Serum miR-1290
as a marker of pancreatic cancer - response. Clin Cancer Res.
19:5252–5253. 2013. View Article : Google Scholar
|
7
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PloS
One. 8:e736042013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lynam-Lennon N, Maher SG and Reynolds JV:
The roles of microRNA in cancer and apoptosis. Biol Rev. 84:55–71.
2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li M, Li J, Ding X, He M and Cheng S-Y:
microRNA and cancer. AAPS J. 12:309–317. 2010. View Article : Google Scholar
|
11
|
Liu N, Jiang N, Guo R, et al: MiR-451
inhibits cell growth and invasion by targeting MIF and is
associated with survival in nasopharyngeal carcinoma. Mol Cancer.
12:1232013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang T, Zang W-Q, Li M, Wang N, Zheng Y-l
and Zhao G-Q: Effect of miR-451 on the biological behavior of the
esophageal carcinoma cell line EC9706. Dig Dis Sci. 58:706–714.
2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tian Y, Nan Y, Han L, et al: MicroRNA
miR-451 downregulates the PI3K/AKT pathway through CAB39 in human
glioma. Int J Oncol. 40:1105–1112. 2012.PubMed/NCBI
|
14
|
Nan Y, Han L, Zhang A, et al: MiRNA-451
plays a role as tumor suppressor in human glioma cells. Brain Res.
1359:14–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sakamoto Y, Mafune K, Mori M, et al:
Overexpression of MMP-9 correlates with growth of small
hepatocellular carcinoma. Int J Oncol. 17:237–243. 2000.PubMed/NCBI
|
16
|
Chen R, Cui J, Xu C, Xue T, Guo K, Gao D,
Liu Y, Ye S and Ren Z: The significance of MMP-9 over MMP-2 in HCC
invasiveness and recurrence of hepatocellular carcinoma after
curative resection. Ann Surg Oncol. 19(Suppl): S375–S384. 2012.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Lakka SS, Gondi CS, Yanamandra N, et al:
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma
cell line via RNA interference reduces tumor cell invasion, tumor
growth and angiogenesis. Oncogene. 23:4681–4689. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
19
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang L, Yao J, Shi X, et al: MicroRNA-302b
suppresses cell proliferation by targeting EGFR in human
hepatocellular carcinoma SMMC-7721 cells. BMC Cancer. 13:4482013.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Nautiyal J, Banerjee S, Kanwar SS, et al:
Curcumin enhances dasatinib-induced inhibition of growth and
transformation of colon cancer cells. Int J Oncol. 128:951–961.
2011.PubMed/NCBI
|
23
|
Liu Z-H, He Y-P and Qin H: The
growth-inhibition effect of tamoxifen in the combination
chemotherapeutics on the human cholangiocarcinoma cell line QBC939.
Mol Biol Rep. 37:2693–2701. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Liu E, Kuang Y, He W, Xing X and Gu J:
Casticin induces human glioma cell death through apoptosis and
mitotic arrest. Cell Physiol Biochem. 31:805–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
D’Amelio M, Sheng M and Cecconi F:
Caspase-3 in the central nervous system: beyond apoptosis. Trends
Neurosci. 35:700–709. 2012.
|
26
|
Ying TH, Yang SF, Tsai SJ, et al: Fisetin
induces apoptosis in human cervical cancer HeLa cells through
ERK1/2-mediated activation of caspase-8-/caspase-3-dependent
pathway. Arch Toxicol. 86:263–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Persad R, Liu C, Wu T-T, et al:
Overexpression of caspase-3 in hepatocellular carcinomas. Mod
Pathol. 17:861–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Bandres E, Bitarte N, Arias F, et al:
microRNA-451 regulates macrophage migration inhibitory factor
production and proliferation of gastrointestinal cancer cells. Clin
Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Leifler KS, Svensson S, Abrahamsson A, et
al: Inflammation induced by MMP-9 enhances tumor regression of
experimental breast cancer. J Immunol. 190:4420–4430. 2013.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lee L-Y, Wu C-M, Wang C-C, et al:
Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric
cancer and their relation to claudin-4 expression. Histol
Histopathol. 23:515–521. 2008.PubMed/NCBI
|
33
|
Roomi M, Monterrey J, Kalinovsky T, Rath M
and Niedzwiecki A: Patterns of MMP-2 and MMP-9 expression in human
cancer cell lines. Oncol Rep. 21:1323–1333. 2009.PubMed/NCBI
|
34
|
Piao S, Zhao S, Guo F, et al: Increased
expression of CD147 and MMP-9 is correlated with poor prognosis of
salivary duct carcinoma. J Cancer Res Clin Oncol. 138:627–635.
2012. View Article : Google Scholar : PubMed/NCBI
|